Suzanne M. Mccluskey

Infectious Disease
55 Fruit St
Boston, MA 02114

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 40 publications

COVID-19 vaccination among people with HIV in Uganda: lessons from a high-risk group with high vaccine uptake for the next pandemic.

COVID-19 vaccination among people with HIV in Uganda: lessons from a high-risk group with high vaccine uptake for the next pandemic.

Journal: Vaccine
Published: December 24, 2025

Preventing weight gain for people living with HIV in rural KwaZulu-Natal, South Africa: A qualitative study of perspectives and strategies.

Preventing weight gain for people living with HIV in rural KwaZulu-Natal, South Africa: A qualitative study of perspectives and strategies.

Journal: HIV medicine
Published: November 18, 2025

Extensive diversity and impact of drug-resistant HIV-1 variants in individuals with prior virologic failure.

Extensive diversity and impact of drug-resistant HIV-1 variants in individuals with prior virologic failure.

Journal: PLoS pathogens
Published: August 11, 2025

Extensive diversity and impact of drug-resistant HIV-1 variants in individuals with prior virologic failure.

Extensive diversity and impact of drug-resistant HIV-1 variants in individuals with prior virologic failure.

Journal: PLoS pathogens
Published: August 11, 2025

Evaluating the Efficacy of Crushed Bictegravir/Emtricitabine/Tenofovir Alafenamide Administered via Tube.

Evaluating the Efficacy of Crushed Bictegravir/Emtricitabine/Tenofovir Alafenamide Administered via Tube.

Journal: Open forum infectious diseases
Published: June 27, 2025

The clinical and economic impact of genotypic resistance testing for people diagnosed with persistent virological non-suppression on tenofovir-lamivudine-dolutegravir in South Africa: a modelling study.

The clinical and economic impact of genotypic resistance testing for people diagnosed with persistent virological non-suppression on tenofovir-lamivudine-dolutegravir in South Africa: a modelling study.

Journal: The lancet. HIV
Published: March 27, 2025

Predictors of treatment-emergent resistance to dolutegravir.

Predictors of treatment-emergent resistance to dolutegravir.

Journal: The lancet. HIV
Published: March 06, 2025

Lenacapavir-associated drug resistance: implications for scaling up long-acting HIV pre-exposure prophylaxis.

Lenacapavir-associated drug resistance: implications for scaling up long-acting HIV pre-exposure prophylaxis.

Journal: The lancet. HIV
Published: February 25, 2025

Approaches to the Management of Virologic Failure on Dolutegravir-Based Antiretroviral Therapy in the 50 Countries With the Highest Adult HIV Prevalence.

Approaches to the Management of Virologic Failure on Dolutegravir-Based Antiretroviral Therapy in the 50 Countries With the Highest Adult HIV Prevalence.

Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: February 21, 2025

Factors Associated With Incomplete Adherence to Dolutegravir-Based Antiretroviral Therapy in Southwestern Uganda.

Factors Associated With Incomplete Adherence to Dolutegravir-Based Antiretroviral Therapy in Southwestern Uganda.

Journal: Journal of acquired immune deficiency syndromes (1999)
Published: November 20, 2024

Brief Report: Dolutegravir-Based Therapy, Diet, Physical Activity, and Weight Gain: A 48-week Prospective Cohort in South Africa.

Brief Report: Dolutegravir-Based Therapy, Diet, Physical Activity, and Weight Gain: A 48-week Prospective Cohort in South Africa.

Journal: Journal of acquired immune deficiency syndromes (1999)
Published: November 17, 2024

Evaluation of antiretroviral regimen switching options in adults with HIV with sustained viral load non-suppression on dolutegravir, lamivudine, and tenofovir in eastern, central, southern, and western Africa: a modelling study.

Evaluation of antiretroviral regimen switching options in adults with HIV with sustained viral load non-suppression on dolutegravir, lamivudine, and tenofovir in eastern, central, southern, and western Africa: a modelling study.

Journal: The lancet. HIV
Published: October 14, 2024
Showing 1-12 of 40

Last Updated: 09/26/2026